ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin thera ...
The Alamo Colleges District is creating the School for Online Learning, advancing the district’s commitment to expanding ...
For many, improving your financial situation may feel impossible, but there’s a local program that can pay your tuition, ...
Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—includin ...
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...
Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...
Arcellx, Inc. , a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced it will ...
Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly ...
Being a member of the Oklahoma men’s golf team, the Cheboygan native is all over the country competing in some of the biggest college tournaments out there. NM OPEN FIRST ROUND RESULTS: Maybank leads ...
Alamo Colleges District board approved a new School of Online Learning with aims to expand flexible, accessible education for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback